Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Bristol-Myers Squibb Company(BMY) | 716,297 | 702,298 | -13,999 | $41.57M | $36.03M | 28.19% | -$5.54M |
| Neurocrine Biosciences, Inc.(NBIX) | 77,240 | 77,240 | 0 | $8.69M | $10.18M | 7.96% | +$1.49M |
| Biodesix, Inc.(BDSX) | 5,348,273 | 5,348,273 | 0 | $8.74M | $9.79M | 7.66% | +$1.05M |
| Acadia Pharmaceuticals Inc | 240,400 | 240,400 | 0 | $5.01M | $7.53M | 5.89% | +$2.52M |
| Prothena Corp PlcSHS SHS | 169,574 | 169,574 | 0 | $8.18M | $6.16M | 4.82% | -$2.02M |
| Immunogen Inc | 190,000 | 188,000 | -2,000 | $3.02M | $5.57M | 4.36% | +$2.56M |
| Quidelortho Corp | 65,203 | 65,203 | 0 | $4.76M | $4.81M | 3.76% | +$43.0K |
| Ovintiv Inc.(OVV) | 84,200 | 84,200 | 0 | $4.01M | $3.70M | 2.89% | -$307.3K |
| Elutia Inc.(ELUT) | 1,655,184 | 1,655,184 | 0 | $2.37M | $3.58M | 2.80% | +$1.21M |
| Phreesia, Inc.(PHR) | 82,700 | 114,700 | +32,000 | $1.54M | $2.66M | 2.08% | +$1.11M |
| United Therapeutics Corporation(UTHR) | 11,000 | 11,000 | 0 | $2.48M | $2.42M | 1.89% | -$65.8K |
| Cytokinetics, Incorporated(CYTK) | 25,000 | 25,000 | 0 | $736.5K | $2.09M | 1.63% | +$1.35M |
| Foghorn Therapeutics Inc.(FHTX) | 264,843 | 320,930 | +56,087 | $1.32M | $2.07M | 1.62% | +$745.8K |
| Silk Road Medical Inc | 41,294 | 158,094 | +116,800 | $619.0K | $1.94M | 1.52% | +$1.32M |
| Inhibrx Inc | 70,448 | 48,448 | -22,000 | $1.29M | $1.84M | 1.44% | +$548.3K |
| Masimo Corp | 15,280 | 15,280 | 0 | $1.34M | $1.79M | 1.40% | +$451.2K |
| Harrow, Inc.(HROW) | 150,000 | 150,000 | 0 | $2.16M | $1.68M | 1.31% | -$475.5K |
| 10x Genomics, Inc.CL A(TXG) | 21,000 | 30,000 | +9,000 | $866.3K | $1.68M | 1.31% | +$812.5K |
| Corcept Therapeutics Incorporated(CORT) | 50,000 | 50,000 | 0 | $1.36M | $1.62M | 1.27% | +$261.8K |
| Alkermes plcSHS(ALKS) | 50,000 | 50,000 | 0 | $1.40M | $1.39M | 1.09% | -$13.5K |
| Equitrans Midstream Corporatio | 133,050 | 133,050 | 0 | $1.25M | $1.35M | 1.06% | +$107.8K |
| Alphatec Holdings, Inc.(ATEC) | 80,000 | 88,000 | +8,000 | $1.04M | $1.33M | 1.04% | +$292.1K |
| Axogen, Inc.(AXGN) | 173,000 | 173,000 | 0 | $865.0K | $1.18M | 0.92% | +$316.6K |
| Stoke Therapeutics, Inc.(STOK) | 85,000 | 210,000 | +125,000 | $334.9K | $1.10M | 0.86% | +$769.7K |
| Protagonist Therapeutics Inc | 38,000 | 48,000 | +10,000 | $633.8K | $1.10M | 0.86% | +$466.8K |
| Travere Therapeutics, Inc.(TVTX) | 82,000 | 122,000 | +40,000 | $733.1K | $1.10M | 0.86% | +$363.7K |
| Apellis Pharmaceuticals Inc COM | 18,000 | 18,000 | 0 | $684.7K | $1.08M | 0.84% | +$392.8K |
| Accelerate Diagnostics Inc | 225,239 | 225,239 | 0 | $1.30M | $882.9K | 0.69% | -$412.2K |
| Pioneer Natural Resources Co | 3,800 | 3,800 | 0 | $872.3K | $854.5K | 0.67% | -$17.7K |
| DocGo Inc.(DCGO) | 130,000 | 150,000 | +20,000 | $692.9K | $838.5K | 0.66% | +$145.6K |
| Progyny Inc | 18,000 | 22,000 | +4,000 | $612.4K | $818.0K | 0.64% | +$205.6K |
| Arvinas, Inc.(ARVN) | 15,000 | 15,000 | 0 | $294.6K | $617.4K | 0.48% | +$322.8K |
| Kiniksa Pharmaceuticals Ltd | 30,000 | 30,000 | 0 | $521.1K | $526.2K | 0.41% | +$5.1K |
| Kalvista Pharmaceuticals Inc | 40,000 | 40,000 | 0 | $385.2K | $490.0K | 0.38% | +$104.8K |
| Xenon Pharmaceuticals Inc.(XENE) | 10,000 | 10,000 | 0 | $341.6K | $460.6K | 0.36% | +$119.0K |
| Bluebird Bio Inc | 455,200 | 321,200 | -134,000 | $1.38M | $443.3K | 0.35% | -$940.6K |
| Karyopharm Therapeutics Inc.(KPTI) | 571,832 | 469,832 | -102,000 | $766.3K | $406.4K | 0.32% | -$359.9K |
| Amicus Therapeutics Inc COM | 28,000 | 28,000 | 0 | $340.5K | $397.3K | 0.31% | +$56.8K |
| Halozyme Therapeutics, Inc.(HALO) | 10,000 | 10,000 | 0 | $382.0K | $369.6K | 0.29% | -$12.4K |
| Coherus Oncology, Inc.(CHRS) | 0 | 110,000 | +110,000 | $0 | $366.3K | 0.29% | +$366.3K |
| Springworks Therapeutics Inc | 0 | 10,000 | +10,000 | $0 | $365.0K | 0.29% | +$365.0K |
| Biohaven Pharmaceutical Holding Co Ltd | 0 | 7,365 | +7,365 | $0 | $315.2K | 0.25% | +$315.2K |
| Keros Therapeutics, Inc.(KROS) | 7,000 | 7,000 | 0 | $223.2K | $278.3K | 0.22% | +$55.2K |
| Xencor, Inc.(XNCR) | 12,300 | 12,300 | 0 | $247.8K | $261.1K | 0.20% | +$13.3K |
| Cullinan Therapeutics, Inc.(CGEM) | 25,114 | 25,114 | 0 | $227.3K | $255.9K | 0.20% | +$28.6K |
| G1 Therapeutics Inc | 120,000 | 80,000 | -40,000 | $172.8K | $244.0K | 0.19% | +$71.2K |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 0 | 16,000 | +16,000 | $0 | $242.4K | 0.19% | +$242.4K |
| Sarepta Therapeutics, Inc.(SRPT) | 2,500 | 2,500 | 0 | $303.1K | $241.1K | 0.19% | -$62.0K |
| Liquidia Corporation(LQDA) | 0 | 20,000 | +20,000 | $0 | $240.6K | 0.19% | +$240.6K |
| Cabaletta Bio, Inc.(CABA) | 0 | 10,000 | +10,000 | $0 | $227.0K | 0.18% | +$227.0K |
| Castle Biosciences, Inc.(CSTL) | 0 | 10,000 | +10,000 | $0 | $215.8K | 0.17% | +$215.8K |
| Wave Life Sciences, Inc.SHS(WVE) | 0 | 40,000 | +40,000 | $0 | $202.0K | 0.16% | +$202.0K |
| Gossamer Bio, Inc.(GOSS) | 209,088 | 138,176 | -70,912 | $174.1K | $126.1K | 0.10% | -$48.0K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 20,000 | 20,000 | 0 | $141.6K | $119.8K | 0.09% | -$21.8K |
| 2seventy Bio Inc | 59,833 | 19,833 | -40,000 | $234.5K | $84.7K | 0.07% | -$149.9K |
| InflaRx N.V.(IFRX) | 50,000 | 50,000 | 0 | $149.0K | $81.5K | 0.06% | -$67.5K |
| Ventyx Biosciences Inc | 26,400 | 28,800 | +2,400 | $916.9K | $71.1K | 0.06% | -$845.7K |
| Yield10 Bioscience Inc | 18,750 | 18,750 | 0 | $6.1K | $4.5K | 0.00% | -$1.6K |
| NEKTAR THERAPEUTICSCOM(NKTR) | 28,000 | 0 | -28,000 | $16.7K | $0 | — | -$16.7K |